Cases 1 - 3 of 3
Cipla USA, Inc. v. Ipsen Biopharmaceuticals, Inc.
as 1:2022cv00552
Plaintiff:
Cipla USA, Inc.
Defendant:
Ipsen Biopharmaceuticals, Inc.
Cause Of Action: 15 U.S.C. § 1125 Trademark Infringement (Lanham Act)
In re: Sensipar (Cinacalcet Hydrochloride Tablets) Antitrust Litigation
as 1:2019md02895
Not Classified By Court:
UFCW Local 1500 Welfare Fund, Actavis Pharma Inc., Cipla Ltd. and others
Plaintiff:
Cesar Castillo, Inc. and KPH HEALTHCARE SERVICES, INC.
In Re:
In re: Sensipar (Cinacalcet Hydrochloride Tablets) Antitrust Litigation
Cause Of Action: 15 U.S.C. § 1
Cipla Ltd. et al v. Amgen Inc.
as 1:2019cv00044
Defendant:
Amgen Inc. and Teva Pharmaceuticals USA, Inc.
Plaintiff:
Cipla USA, Inc. and Cipla Ltd.
Cause Of Action: 15 U.S.C. § 1
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
